Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma crawled time : 11:00 save search
Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Published: 2024-04-17 (Crawled : 11:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
reminyl pharma acquisition
Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -5.43%
H: 1.84%
C: -15.57%
pharma medical
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 4.9%
H: 6.03%
C: 3.11%
fosgonimeton pharma disease alzheimer’s publication treatment preclinical
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
HOOK | $0.7317 -4.34% -4.54% 420K
|
Health Technology
|
| O: 1.02%
H: 1.76%
C: -2.36%
hb-200 pharma
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
INZY | $4.5 -1.75% -1.78% 590K
|
Health Technology
|
| O: 2.2%
H: 7.69%
C: -9.69%
inz-701 pharma positive ongoing trials topline
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published: 2024-04-05 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: -5.22%
pharma report universal
Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-03 (Crawled : 11:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -3.23%
H: 0.0%
C: 0.0%
pharma presentation meeting
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
ROIV | $10.46 0.97% 0.96% 4.7M
|
Manufacturing
|
| O: 4.79%
H: 3.02%
C: -0.09%
pharma million authorization positive repurchase results study
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-03-22 (Crawled : 11:00) - globenewswire.com
HOOK | $0.7317 -4.34% -4.54% 420K
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -5.19%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.03%
H: 0.16%
C: -0.68%
pharma business year financial results
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.78%
H: 1.93%
C: 0.97%
iph45 pharma drug antibody preclinical
Poolbeg Pharma PLC Announces Further Data Shows POLB001 Potential in Cancer CRS
Published: 2024-01-17 (Crawled : 11:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
polb001 pharma cancer potential
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published: 2024-01-12 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 0.36%
C: 0.36%
pharma
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published: 2023-11-27 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.04%
H: 0.17%
C: 0.11%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.07%
H: 1.21%
C: 1.21%
pharma
HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences
Published: 2023-10-18 (Crawled : 11:00) - globenewswire.com
HOOK | $0.7317 -4.34% -4.54% 420K
|
Health Technology
|
| O: 3.19%
H: 0.98%
C: -1.98%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.01%
H: 0.3%
C: -0.99%
hepatitis pharma vaccine publication sciences preclinical collaboration virus
LEO Pharma Connects Affiliates with Veeva Vault Safety to Transform Safety Operations
Published: 2023-10-03 (Crawled : 11:00) - prnewswire.com
VEEV | $198.38 -0.58% 0.0% 730K
|
Technology Services
|
| O: -0.6%
H: 1.4%
C: 0.14%
leo pharma
MEI Pharma Adopts Limited-Duration Stockholder Rights Plan
Published: 2023-10-02 (Crawled : 11:00) - biospace.com/
MEIP | $3.3 1.54% 1.52% 26K
|
Health Technology
|
| O: -0.86%
H: 2.16%
C: 0.43%
pharma
Athira Pharma to Participate in Upcoming October Conferences
Published: 2023-09-28 (Crawled : 11:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: -0.53%
H: 6.35%
C: 5.82%
pharma
NewAmsterdam Pharma Announces Initial Data from Phase 2a Clinical Trial Evaluating Obicetrapib in Patients with Early Alzheimer’s Disease Who Carry an ApoE4 Mutation
Published: 2023-09-21 (Crawled : 11:00) - globenewswire.com
NAMS | $19.98 2.78% 2.7% 140K
|
n/a
|
| O: -0.91%
H: 1.94%
C: 0.2%
pharma disease alzheimer’s trial
Athira Pharma to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
Published: 2023-09-19 (Crawled : 11:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 0.0%
H: 5.13%
C: 4.62%
pharma conference global
Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023
Published: 2023-09-19 (Crawled : 11:00) - globenewswire.com
VINC | $0.8475 -5.83% -6.19% 350K
|
|
| O: 4.05%
H: 0.0%
C: -0.65%
pharma conference global
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.